Multi-omic profiling reveals metabolic vulnerabilities in enzalutamide resistant prostate cancer

Olivia Lee, Gio Fidelito, Qing Zhao, Bingshou Liu, Hyungwon Choi, Renea A. Taylor, Matthew J. Watt

Open source

DOI
10.1038/s41420-026-03332-3
Published
2026-09-09
Container
Cell Death Discovery
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41420-026-03332-3,
  title = {Multi-omic profiling reveals metabolic vulnerabilities in enzalutamide resistant prostate cancer},
  author = {Olivia Lee and Gio Fidelito and Qing Zhao and Bingshou Liu and Hyungwon Choi and Renea A. Taylor and Matthew J. Watt},
  year = {2026},
  journal = {Cell Death Discovery},
  doi = {10.1038/s41420-026-03332-3},
  url = {https://doi.org/10.1038/s41420-026-03332-3}
}

RIS

TY  - JOUR
TI  - Multi-omic profiling reveals metabolic vulnerabilities in enzalutamide resistant prostate cancer
AU  - Olivia Lee
AU  - Gio Fidelito
AU  - Qing Zhao
AU  - Bingshou Liu
AU  - Hyungwon Choi
AU  - Renea A. Taylor
AU  - Matthew J. Watt
PY  - 2026
JO  - Cell Death Discovery
DO  - 10.1038/s41420-026-03332-3
UR  - https://doi.org/10.1038/s41420-026-03332-3
ER  - 

APA

Lee, O., Fidelito, G., Zhao, Q., Liu, B., Choi, H., Taylor, R. A., & Watt, M. J. (2026). Multi-omic profiling reveals metabolic vulnerabilities in enzalutamide resistant prostate cancer. Cell Death Discovery. https://doi.org/10.1038/s41420-026-03332-3

Source records